Patents by Inventor Victoria A. Johnson

Victoria A. Johnson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition and method for detecting an adulterant in an aqueous sample
    Publication number: 20050048663
    Abstract: It is discovered that a composition comprising at least one amine and at least one stabilizer may be useful in detecting the presence of an adulterant in a urine sample. Such adulterant includes an oxidizing agent.
    Type: Application
    Filed: August 4, 2004
    Publication date: March 3, 2005
    Applicant: Quest Diagnostics Investments Incorporated
    Inventors: John Novinski, Barry Sample, Richard Hilderbrand, Susan Mills, Victoria Johnson
  • Composition and method for detecting an adulterant in an aqueous sample
    Patent number: 6861262
    Abstract: It is discovered that a composition comprising at least one amine and at least one stabilizer may be useful in detecting the presence of an adulterant in a urine sample. Such adulterant includes an oxidizing agent.
    Type: Grant
    Filed: June 6, 2001
    Date of Patent: March 1, 2005
    Assignee: Quest Diagnostics Investments Incorporated
    Inventors: John Novinski, Barry Sample, Richard L. Hilderbrand, Susan Mills, Victoria Johnson
  • Composition and method for detecting an adulterant in an aqueous sample
    Publication number: 20020106807
    Abstract: It is discovered that a composition comprising at least one amine and at least one stabilizer may be useful in detecting the presence of an adulterant in a urine sample. Such adulterant includes an oxidizing agent.
    Type: Application
    Filed: June 6, 2001
    Publication date: August 8, 2002
    Applicant: Quest Diagnostics, Inc.
    Inventors: John Novinski, Barry Sample, Richard L. Hilderbrand, Susan Mills, Victoria Johnson
  • Pharmaceutical composition and method of inhibiting virus
    Patent number: 5011829
    Abstract: A pharmaceutical composition and a method of inhibiting human immunodeficiency virus (HIV) is disclosed which comprises administering to an HIV infected patient a synergistic combination of 3'-azido-3'-deoxythymidine (AZT) and N-butyl deoxynojirimycin (N-butyl DNJ) in an amount which achieves antiviral efficacy.
    Type: Grant
    Filed: June 2, 1989
    Date of Patent: April 30, 1991
    Assignee: G. D. Searle & Co.
    Inventors: Martin S. Hirsch, Victoria A. Johnson